Forrest A P, Stewart H J, Roberts M M, Steele R J
Ann Surg. 1982 Sep;196(3):371-8. doi: 10.1097/00000658-198209000-00017.
Axillary node sampling was introduced as a means of defining those patients whose primary breast cancer was treated by simple mastectomy in whom postoperative radiotherapy could be avoided safely. The authors have initiated controlled randomized trials in Cardiff and Edinburgh which have indicated that, provided that nodes are identified for histologic examination, simple mastectomy, node sampling, and selective radiotherapy give equal survival rates to routine radical treatment, whether this is by surgery or radiotherapy. Provided sampling of nodes is adequate and histologically proven, locoregional control also is satisfactory. A current randomized trial comparing this policy with Patey mastectomy has allowed comparative studies of axillary node status. These and follow-up data indicate that for a valid assessment, three to four nodes should be identified by the surgeon for histologic examination, the false negative rate being less than 10%.
腋窝淋巴结取样作为一种手段被引入,用于确定那些原发性乳腺癌采用单纯乳房切除术治疗且术后可安全避免放疗的患者。作者在加的夫和爱丁堡开展了对照随机试验,结果表明,只要对淋巴结进行组织学检查,单纯乳房切除术、淋巴结取样和选择性放疗与常规根治性治疗(无论是手术还是放疗)的生存率相同。只要淋巴结取样充分且经组织学证实,局部区域控制也令人满意。目前一项将该策略与帕蒂乳房切除术进行比较的随机试验,使得对腋窝淋巴结状态进行了对比研究。这些以及随访数据表明,为了进行有效评估,外科医生应识别三到四个淋巴结进行组织学检查,假阴性率应小于10%。